224060.KQ Loading... : Bullish and Bearish Analyst Opinions

Loading chart...
Top Calls
Feed
All Sources
YouTube
Twitter
Reddit
Substack
Insider
Loading...
0 selected
All Content
Source feeds
Buzzberg's Top 50
All directions
▲ Long
▼ Short
◦ Others
Any score
LOW+
MED+
HIGH
00:20
May 28
DND Pharmatech trial catalyst
DND Pharmatech surged on positive MASH (metabolic fatty liver) phase 1 trial results. The pipeline is worth 2-5 trillion won, and successful licensing could propel the stock much higher.
HIGH

About 224060.KQ Analyst Coverage

Buzzberg tracks 224060.KQ across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade ideas tracked.